It has been reported that drug resistance can be prevented in cancer cells by inhibiting the Ras/Raf/MEK/ERK, PI3K/AKT pathways, and key transcription factors, such as NF-κB and HIF-1α [1]. Here, HIF1A is linked to cancer.